Vimarsana
Biggest News Aggregation in the World

Rapid Vertical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rapid Vertical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rapid Vertical Today - Breaking & Trending Today

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System - Vimarsana News

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System

HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this new patent, MedMira...

Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and - Vimarsana News

Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and

PROVIDENCE, R.I. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--#HIV--Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a developer and manufacturer of rapid diagnostics, today announced that the companies have entered into a multin...

MedMira, Inc.: MedMira Enters into Partnership with Maternova for USA and Latin America - Vimarsana News

MedMira, Inc.: MedMira Enters into Partnership with Maternova for USA and Latin America

HALIFAX, NS / ACCESSWIRE / February 20, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with ?Maternova, Inc., Rhode Island, USA. ?Maternova

MedMira, Inc.: MedMira receives CE mark for its VYRA CoV2Flu Antigen Test - Vimarsana News

MedMira, Inc.: MedMira receives CE mark for its VYRA CoV2Flu Antigen Test

HALIFAX, NS / ACCESSWIRE / January 11, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA CoV2Flu Antigen Test (VYRA CoV2Flu), the fastest combination antigen

MedMira, Inc.: Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira's RVF Technology - Vimarsana News

MedMira, Inc.: Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira's RVF Technology

HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually